Fondaparinux is an anticoagulant medication used to prevent blood clots. However, like any pharmaceutical product, it may contain impurities that can affect its quality and safety. These impurities can include residual solvents, degradation products, and other unwanted substances that may have a negative impact on the drug's efficacy or cause adverse effects in patients. It is essential to monitor and control these impurities during the manufacturing process to ensure that the final product meets the required standards of purity and
